Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1626 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Eisai To Begin Rufinamide Clinical Trial In Japan

Rufinamide is a triazole derivative that is structurally unrelated to currently marketed antiepileptic drugs (AEDs). It is believed to exert its antiepileptic effects by regulating the activity of

Watson, Teva Settle Seasonale Patent Dispute

Under terms of the settlement agreement, Teva has granted Watson a fully paid-up license to the US patents covering Seasonale and Watson is expected to continue marketing its